Haitao Ma

机构：Sichuan Agricultural University · ORCID：0000-0002-2913-8033

发表论文 37 篇 · 总被引 622 次 · h-index 12

代表论文

• Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial (2021 · The Lancet Respiratory Medicine · 被引 192)
• Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes (2021 · Nature Communications · 被引 77)
• Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study (2021 · JTO Clinical and Research Reports · 被引 35)
• LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑ HSPA9 (2021 · Oncology Reports · 被引 19)
• Multi‐omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma (2023 · Clinical and Translational Medicine · 被引 18)
• Dopamine Pathway Mediated by DRD5 Facilitates Tumor Growth via Enhancing Warburg Effect in Esophageal Cancer (2021 · Frontiers in Oncology · 被引 15)